A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors
A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors
Recruiting · NCT07160725 · Registry updated 2026-08-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors | Solid Tumours | Recruiting | Phase 1 / Phase 2 | 2026-08-11 | NCT07160725 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bristol-Myers Squibb | 422 |
14 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Clinica Universidad de Navarra | Pamplona | Spain | 58 |
| Copenhagen University Hospital Rigshospitalet | Copenhagen | Denmark | 2 |
| Fred Hutchinson Cancer Center | Seattle | United States | 250 |
| Herlev and Gentofte Hospital | Copenhagen | Denmark | 7 |
| Hospital Universitario Fundación Jiménez Díaz | Madrid | Spain | 61 |
| National Cancer Center Hospital | Chuo-ku | Japan | 67 |
| Odense Universitetshospital | Odense | Denmark | 12 |
| Sanford Cancer Center | Sioux Falls | United States | 12 |
| START - Dallas Fort Worth | Fort Worth | United States | 1 |
| START Mountain Region | West Valley City | United States | 46 |
| START San Antonio | San Antonio | United States | 30 |
| University of California, Irvine (UCI) Health - UC Irvine Medical Center | Orange | United States | 2 |
| UPMC Hillman Cancer Center | Pittsburgh | United States | 330 |
| USC/Norris Comprehensive Cancer Center | Los Angeles | United States | 35 |